Funding search · EIN 473425850 · Dallas, TX

Cancer Prevention Initiative

Name: Cancer Prevention Initiative grants, 2023–2025
Creator: PaperOrbit
License: https://www.irs.gov/charities-non-profits/exempt-organization-public-disclosure-and-availability-requirements

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

6
grants reported: $1.6M
total given: 2023–2025
filing years: $200,000
median grant

Based on grants this organization reported to the IRS for tax years 2023–2025. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

Funder website ↗Full IRS filings ↗How this is built Report an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

1 grant matching “allelic” · $150,000

$150,000
Memorial Sloan Kettering Cancer Center · New York, NY · 2025
This project to identify factors that influence the Loss of Heterozygosity (LOH) was initially funded in 2019. Based on the significant progress made in the project, the project was granted additional funding to continu… read allThis project to identify factors that influence the Loss of Heterozygosity (LOH) was initially funded in 2019. Based on the significant progress made in the project, the project was granted additional funding to continue to phase 2 in 2021 and phase 3 in 2024-2025. During phase 3, they will study allele loss under BRCA wildtype and heterozygous conditions. These studies will provide a comparative mechanistic understanding of LOH at BRCA under normal and carrier conditions. This mechanistic understanding will facilitate development of strategies to prevent LOH and thereby prevent cancer development in high-risk individuals. less

Grant history

All 6 reported grants, largest first.

$450,000
University of Texas Md Anderson Cancer Center · Houston, TX · 2025
The purpose of the Grant is for the Principal Investigator to carry out the research to develop immune interventions that could reduce the risk of Lynch Syndrome (LS)-related cancers. The goals of the project are to dev… read allThe purpose of the Grant is for the Principal Investigator to carry out the research to develop immune interventions that could reduce the risk of Lynch Syndrome (LS)-related cancers. The goals of the project are to develop vaccines and test their potential to prevent colorectal cancer in a preclinical model of LS and to explore the colonic immune microenvironment. less
$450,000
Dana Farber Cancer Institute · Boston, MA · 2024
The objective of this project is to identify aberrantly expressed age-related drivers of cancer in individuals with inherited cancer syndromes related to BRCA mutations. This project will help develop preventive measure… read allThe objective of this project is to identify aberrantly expressed age-related drivers of cancer in individuals with inherited cancer syndromes related to BRCA mutations. This project will help develop preventive measures such as vaccines targeting cancer-initiating progenitor cells. less
$200,000
University of Texas Southwestern Medical Center · Dallas, TX · 2024
Scientific and administrative oversight of all Cancer Prevention Initiative programs.
$200,000
University of Texas Southwestern Medical Center · Dallas, TX · 2023
Scientific and administrative oversight of all Cancer Prevention Initiative programs.
$150,000
Memorial Sloan Kettering Cancer Center · New York, NY · 2025
This project to identify factors that influence the Loss of Heterozygosity (LOH) was initially funded in 2019. Based on the significant progress made in the project, the project was granted additional funding to continu… read allThis project to identify factors that influence the Loss of Heterozygosity (LOH) was initially funded in 2019. Based on the significant progress made in the project, the project was granted additional funding to continue to phase 2 in 2021 and phase 3 in 2024-2025. During phase 3, they will study allele loss under BRCA wildtype and heterozygous conditions. These studies will provide a comparative mechanistic understanding of LOH at BRCA under normal and carrier conditions. This mechanistic understanding will facilitate development of strategies to prevent LOH and thereby prevent cancer development in high-risk individuals. less
$125,000
University of Texas Southwestern Medical Center · Dallas, TX · 2025
Scientific and administrative oversight of all Cancer Prevention Initiative programs.

Who else funds this kind of work

Same state

Greater Houston Community Foundation5,612 grants · $873.8M
The Big 12 Conference50 grants · $1.91B
Texas Essential Healthcare Partnerships297 grants · $972.3M

Similar grant size

The Ford Foundation10,731 grants · $2.35B
John D and Catherine T MacArthur Foundation (Consolidated)7,100 grants · $1.67B
Wk Kellogg Foundation7,234 grants · $1.30B

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.